USC-Brookings Schaeffer Initiative for Health Policy
Featured Topics
Lead story
Other featured articles
-
USC-Brookings Schaeffer Initiative Receives $3.6 Million from Arnold Ventures to Examine Rising Healthcare Spending
The project will focus on physician consolidation, surprise billing, out-of-pocket spending and policies to address healthcare prices.
-
High Air Ambulance Charges Concentrated in Private Equity- Owned Carriers
Private equity firm-owned air ambulance services charge markedly higher rates than other types of providers of the same service, according to new research.
-
A Supreme Court Decision to Strike Down the ACA Would Create Chaos in the Healthcare System
On November 10, the Supreme Court will hear oral argument in California v. Texas, the case in which the Trump Administration and a group of Attorneys General are challenging the constitutionality of the Affordable Care Act (ACA).
-
Surprise Medical Bills Increase Costs for Everyone, Not Just for the People Who Get Them
About 12% of insurers’ U.S. spending on in- and out-of-network medical care goes to six types of providers that commonly submit surprise bills.
Posted in
About this section
The USC-Brookings Schaeffer Initiative for Health Policy is a partnership between Economic Studies at Brookings and the USC Schaeffer Center for Health Policy & Economics, and aims to inform the national health care debate with rigorous, evidence-based analysis leading to practical recommendations using the collaborative strengths of USC and Brookings.
Experts
Work from the USC-Brookings Schaeffer Initiative for Health Policy
-
GAO Report Sheds Additional Light on Misleading and Deceptive Marketing Practices Among Non-Compliant Health Plans
The GAO report underscores three key themes: misleading information is shockingly prevalent, a wide variety of junk plans are sold and may frequently be bundled together, and fixed indemnity plans appear to play a large role.
-
NEJM: Competing Visions for the Future of Health Policy
Beyond Covid-19, two other health policy issues are poised to feature prominently in the 2020 U.S. elections: what role government should play in ensuring broad health insurance coverage, and how to cope with the lack of competition in many health care provider markets.
-
COVID-19 May Move the Needle on Value-Based Payment
Erin Trish, Elizabeth Fowler, and Paul Ginsburg discussed the future of value-based payment models at a recent webinar viewed by over 500 people.
Categorized in -
Lessons from International Experience in Determining Healthcare Prices
Part 3 of a panel series on health care price regulation honoring Uwe E. Reinhardt (1937-2017)
Categorized in -
Healthcare Price Regulation and Public Options: Assessing Approaches to Increasing the Public Role
Part 2 of a panel series on healthcare price regulation honoring Uwe E. Reinhardt (1937-2017)
Categorized in -
Sharing Drug Rebates With Medicare Part D Patients: Why And How
The percentage of total Medicare Part D drug spending offset by rebates on branded drugs increased from 11% in 2010 to 25% in 2018.